| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.ASN.0000034200.82278.DC |
| P698 | PubMed publication ID | 12397050 |
| P2093 | author name string | Gary C Curhan | |
| Charles E McCulloch | |||
| Chi-Yuan Hsu | |||
| P433 | issue | 11 | |
| P304 | page(s) | 2783-2786 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Iron status and hemoglobin level in chronic renal insufficiency | |
| P478 | volume | 13 |
| Q54989527 | A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease |
| Q34885195 | A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients |
| Q44927431 | Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. |
| Q33412594 | Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study |
| Q33719996 | Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study |
| Q44542363 | Anemia is associated with mortality in kidney-transplanted patients--a prospective cohort study. |
| Q36547312 | Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists |
| Q33751499 | Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006 |
| Q36152904 | Association between the presence of iron deficiency anemia and hemoglobin A1c in Korean adults: the 2011-2012 Korea National Health and Nutrition Examination Survey |
| Q30437163 | Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease |
| Q33684085 | Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? |
| Q36070911 | Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy |
| Q47293465 | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |
| Q50673313 | Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia. |
| Q33638138 | Continuous quality improvement in daily clinical practice: a proof of concept study |
| Q34989324 | Correction of iron deficiency in the cardiorenal syndrome |
| Q34884492 | Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study |
| Q33992079 | Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol |
| Q38287050 | Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease |
| Q37123211 | Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease |
| Q51062985 | Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis. |
| Q36636462 | Erythropoiesis-stimulating agents in kidney and cardiac disease |
| Q37087894 | Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients |
| Q30454001 | Ferumoxytol for the treatment of iron deficiency |
| Q36796801 | Ferumoxytol for treating iron deficiency anemia in CKD |
| Q34628344 | Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial |
| Q42727386 | Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner |
| Q37807903 | Intravenous iron in heart failure: beyond targeting anemia |
| Q38334759 | Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experience |
| Q37042142 | Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004. |
| Q36345535 | Kidneys, hearts, hormones and immunomodulators: integrated understandings |
| Q55089372 | Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. |
| Q39818102 | Managing anaemia of chronic kidney disease |
| Q37510916 | Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off? |
| Q37960638 | Modeling and predicting drug pharmacokinetics in patients with renal impairment. |
| Q24187625 | Oral iron for people with chronic kidney disease |
| Q34085240 | Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury |
| Q39002211 | Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery |
| Q36697772 | Renal anaemia: recent developments, innovative approaches and future directions for improved management |
| Q36738420 | Selected physiologic variables are weakly to moderately associated with 29 biomarkers of diet and nutrition, NHANES 2003-2006. |
| Q47558235 | Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. |
| Q36310906 | Sex, haemoglobin and kidney disease: new perspectives |
| Q47102803 | Special issue: iron therapy in patients with chronic kidney disease. |
| Q28648176 | Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status |
| Q36310909 | The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease |
| Q33412890 | The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data |
| Q35830277 | The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study |
| Q83756057 | [Anemia and iron deficiency in the elderly. Prevalence, diagnostics and new therapeutic options] |
Search more.